CCDC98 Inhibitors

The class of CCDC98 Inhibitors would be defined by compounds that have the ability to modulate the function of CCDC98, which is crucial in the DNA damage response and repair pathways. Since the direct inhibition of CCDC98 is not well-characterized, this class of inhibitors focuses on disrupting the cellular processes that CCDC98 is known to participate in. These processes primarily involve the repair of DNA double-strand breaks through homologous recombination, a highly orchestrated and regulated cellular mechanism.

The inhibitors could work by hampering the formation or stabilization of the complex that CCDC98 forms with other proteins such as BRCA1, or by impeding the recruitment of this complex to sites of DNA damage. Compounds like PARP inhibitors, which prevent the repair of single-strand breaks, can lead to the accumulation of double-strand breaks that CCDC98 would normally help to resolve. DNA-damaging agents such as cisplatin and etoposide can exacerbate the demand on the repair pathway, potentially overloading the CCDC98-mediated response and indirectly inhibiting its function. The inhibitors in this chemical class are diverse in their structure and the mechanisms by which they can influence CCDC98, but they share the common feature of affecting the pathways in which CCDC98 is a critical component. These compounds can alter the cellular response to DNA damage, either by causing an increase in damage through the generation of DNA lesions or by impeding the repair of such damage, thereby indirectly affecting the role of CCDC98 in maintaining genomic stability.